Trial Information
Disease	Metastatic colon cancer
Stage of disease/treatment	IV
Prior therapy	One line of systemic therapy
Type of study	Phase I, open-label, dose-escalation trial via a consecutive parallel-group expansion in colorectal cancer
Primary endpoint	Objective response rate
Secondary endpoints	Progression-free survival